Selection and stability for a recombinant CHO cell line expressing human GM-CSF in gene amplification

被引:0
|
作者
Omasa, T [1 ]
Itami, S [1 ]
Kameoka, D [1 ]
Katakura, Y [1 ]
Suga, K [1 ]
机构
[1] Osaka Univ, Grad Sch Engn, Biochem Engn Lab, Dept Biotechnol, Suita, Osaka 565, Japan
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the relationship between the specific production rate and the concentration of the toxic drug methotrexate (MTX), inhibitory to nucleic acid synthesis in the medium, during the construction of recombinant CHO cells. The results of selection of MTX tolerant cells when the MTX concentration was increased under 10 different stepwise conditions showed that the number of days required to obtain cells resistant to 1000 nM MTX depended on the selection conditions. Tolerant cells were obtained most rapidly at an MTX concentration of 10nM. With increasing MTX concentration, the specific production rate increased, while the specific growth rate gradually decreased. In the case of a gradual increase in the MTX concentration, the specific production rate reached a higher level. We also investigated the stability of the specific production rate during cultivation over a long period with or without MTX. In long-term cultivation, the specific production rate decreased, while the specific growth rate remained at the same level. The specific production rate in a culture without MTX decreased more rapidly than that in a culture with MTX.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [21] Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF
    Klimp, AH
    van der Vaart, E
    Lansink, PO
    Withoff, S
    de Vries, EGE
    Scherphof, GL
    Wilschut, J
    Daemen, T
    GENE THERAPY, 2001, 8 (04) : 300 - 307
  • [22] Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF
    AH Klimp
    E van der Vaart
    PO Lansink
    S Withoff
    EGE de Vries
    GL Scherphof
    J Wilschut
    T Daemen
    Gene Therapy, 2001, 8 : 300 - 307
  • [23] Chronic Inhalation Of Recombinant Human Granulocyte/ macrophage Colony Stimulating Factor (gm-Csf) And Gm-Csf Antibody In Nonhuman Primates
    Tazawa, R.
    Nakagaki, K.
    Ito, Y.
    Iizuka, M.
    Hashimoto, A.
    Nakano, R.
    Tanaka, T.
    Akasaka, K.
    Takeuchi, S.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [24] A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
    Urano, Shinya
    Tazawa, Ryushi
    Nei, Takahito
    Motoi, Natsuki
    Watanabe, Masato
    Igarashi, Takenori
    Tomita, Masahiro
    Nakata, Koh
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2011, (52):
  • [25] GM-CSF production by epithelial cell line: upregulation by ultraviolet A
    Park, KC
    Jung, HC
    Hwang, JH
    Youn, SW
    Ahn, JS
    Park, SB
    Kim, KH
    Chung, JH
    Youn, JI
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 1997, 13 (04) : 133 - 138
  • [26] A LOW-AFFINITY HUMAN GM-CSF ALPHA/BETA CHIMERIC RECEPTOR INDUCES GM-CSF DEPENDENT PROLIFERATION IN A MURINE CELL-LINE
    EDER, M
    ERNST, TJ
    GANSER, A
    HOELZER, D
    GRIFFIN, JD
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 806 - 806
  • [27] INVITRO PRIMING OF HUMAN BONE-MARROW WITH RECOMBINANT GM-CSF
    KORTHOUT, M
    LAN, J
    DEBOCK, R
    VANBOCKSTAELE, D
    PEETERMANS, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (03) : 376 - 377
  • [28] DEVELOPMENT OF ANTIBODIES TO UNPROTECTED GLYCOSYLATION SITES ON RECOMBINANT HUMAN GM-CSF
    GRIBBEN, JG
    DEVEREUX, S
    THOMAS, NSB
    KEIM, M
    JONES, HM
    GOLDSTONE, AH
    LINCH, DC
    LANCET, 1990, 335 (8687): : 434 - 437
  • [29] TREATMENT OF GANCICLOVIR-INDUCED NEUTROPENIA WITH RECOMBINANT HUMAN GM-CSF
    SULECKI, M
    ROSENFELD, CS
    PRZEPIORKA, D
    BLOOM, EJ
    BUHLES, W
    SHADDUCK, RK
    AMERICAN JOURNAL OF MEDICINE, 1991, 90 (03): : 401 - 402
  • [30] A Simplified Method for the Efficient Refolding and Purification of Recombinant Human GM-CSF
    Thomson, Christy A.
    Olson, Melanie
    Jackson, Linda M.
    Schrader, John W.
    PLOS ONE, 2012, 7 (11):